|
AVTX Avalo Therapeutics Inc 1534120 |
| Balance Sheet |
|
Current Assets
|
86,148,000 |
|
Assets
|
98,455,000 |
|
Current Liabilities
|
60,674,000 |
|
Liabilities
|
77,379,000 |
|
Equity
|
21,076,000 |
|
Shares Out
|
9,700,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-34,012,000 |
|
Investing Cash Flow
|
356,000 |
| Market Analysis |
Market Cap
|
9,410,583 |
|
Price
|
6.75 |
|
BVPS
|
2.17 |
|
PB
|
3.01 |
|
EPS
|
-63.82 |
|
PS
|
9.45 |
|
FCF
|
-33,656,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVTX documents filed with the SEC.
AVTX Filings
Clear
